Literature DB >> 27174492

Deep molecular response in chronic myeloid leukemia.

N C P Cross1,2, A Hochhaus3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27174492     DOI: 10.1038/leu.2016.78

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  Reporting results for deep molecular responses in chronic myeloid leukemia.

Authors:  A A Morley
Journal:  Leukemia       Date:  2016-05-17       Impact factor: 11.528

2.  Estimating deep molecular responses in chronic myelogenous leukemia: a Bayesian approach.

Authors:  S S Young; T Tucker; I Bosdet; A Karsan
Journal:  Leukemia       Date:  2016-03-08       Impact factor: 11.528

Review 3.  Standardized definitions of molecular response in chronic myeloid leukemia.

Authors:  N C P Cross; H E White; M C Müller; G Saglio; A Hochhaus
Journal:  Leukemia       Date:  2012-04-16       Impact factor: 11.528

Review 4.  Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia.

Authors:  N C P Cross; H E White; D Colomer; H Ehrencrona; L Foroni; E Gottardi; T Lange; T Lion; K Machova Polakova; S Dulucq; G Martinelli; E Oppliger Leibundgut; N Pallisgaard; G Barbany; T Sacha; R Talmaci; B Izzo; G Saglio; F Pane; M C Müller; A Hochhaus
Journal:  Leukemia       Date:  2015-02-05       Impact factor: 11.528

Review 5.  European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

Authors:  Michele Baccarani; Michael W Deininger; Gianantonio Rosti; Andreas Hochhaus; Simona Soverini; Jane F Apperley; Francisco Cervantes; Richard E Clark; Jorge E Cortes; François Guilhot; Henrik Hjorth-Hansen; Timothy P Hughes; Hagop M Kantarjian; Dong-Wook Kim; Richard A Larson; Jeffrey H Lipton; François-Xavier Mahon; Giovanni Martinelli; Jiri Mayer; Martin C Müller; Dietger Niederwieser; Fabrizio Pane; Jerald P Radich; Philippe Rousselot; Giuseppe Saglio; Susanne Saußele; Charles Schiffer; Richard Silver; Bengt Simonsson; Juan-Luis Steegmann; John M Goldman; Rüdiger Hehlmann
Journal:  Blood       Date:  2013-06-26       Impact factor: 22.113

  5 in total
  1 in total

1.  Hsa-miR-181a-5p, hsa-miR-182-5p, and hsa-miR-26a-5p as potential biomarkers for BCR-ABL1 among adult chronic myeloid leukemia treated with tyrosine kinase inhibitors at the molecular response.

Authors:  Aliza Mohd Yacob; Nor Asiah Muhamad; Kian Meng Chang; Hamidah Akmal Hisham; Yuslina Mat Yusoff; Latifah Ibrahim
Journal:  BMC Cancer       Date:  2022-03-26       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.